The preservation of living cells and tissues is an often-underappreciated obstacle in the clinical lab. Cryogenic temperatures attempt to address this challenge by minimizing biochemical activity within samples of interest. As the cell and gene therapy market grows, the drawbacks of cryopreservation are becoming more apparent. This article examines the current cryopreservation landscape within the […]

X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation – announced today that The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has granted its proprietary organ preservation solution, XT-ViVo®, and TimeSeal® Organ Transport Device, Breakthrough Device status. This designation is granted to products […]

Every day it seems you can find a headline somewhere describing the extraordinary progress scientists have made in developing cell and gene therapies for rare genetic diseases, a variety of cancers, and common ailments that affect most of the industrialized world. Genetic material is now common in vaccines, too, as scientists discovered that mRNA is […]

Living cells, tissues, and organs are more critical to medicine than ever before, but current cryopreservation techniques are not enough to keep these materials viable during storage and transport. Peptoids may provide the solution. Find the whole article here:  European Biopharmaceutical Review | April 2022 This article is taken from European Biopharmaceutical Review April 2022, pages 48-51. © […]